Results 151 to 160 of about 2,756,439 (291)

Resilience to HPV vaccine safety scares in seven countries. [PDF]

J Glob Health
Ellingson MK, Vu M, Waheed DE, Saxena S, de la Hoz FP, Pasternak N, Morrissey Y, Hanley S, Fiscus M, Batmunkh T, Almeida P, Brewer NT.   +11 more
europepmc   +1 more source

Establishment and characterization of mouse lymph node fibrosis models

Animal Models and Experimental Medicine, EarlyView.
The design of the entire paper. Schematic illustration of four strategies for establishing mouse lymph node (LN) fibrosis models. The study further compares their fibrotic remodeling patterns and immune alterations. Abstract Background Lymph node (LN) fibrosis occurs in a variety of pathological conditions, including HIV infection, obesity, cancer, and
Yaru Niu, Xu Guan, Jian Ma, Xin Zhang, Yihang Shi, Jinzhu Zhang, Leiqiong Gao, Wei Chen, Xishan Wang   +8 more
wiley   +1 more source

Unravelling the enhanced vaccine immunity by heterologous KCONVAC/Ad5-nCoV COVID-19 vaccination

Signal Transduction and Targeted Therapy, 2022
Weijun Zhao, Huajun Zhao, Baoying Huang, Tongyi Zhao, Limei Wang, Jian Zhang, Yong Yang, Xinying Tang, Wenjie Tan, Ang Lin   +9 more
doaj   +1 more source

SKYVaricella (a live attenuated varicella vaccine) safety issues revisited. [PDF]

Ewha Med J
Lee J.
europepmc   +1 more source

01-05 STATEMENT OF POLICY

, 2014
Policy Confidence in the safety of the vaccines used to protect the residents of our nation is critical to assuring that the vaccines are used as widely, effectively and appropriately as possible.
Vaccine Safety
core  

Humoral Response and Safety after a Fourth Dose of the SARS-CoV-2 BNT162b2 Vaccine in Cancer Patients Undergoing Active Treatment—Results of a Prospective Observational Study

Only a few studies have been carried out on the efficacy and safety of a fourth dose of the COVID-19 vaccine in patients with cancer. In this prospective observational study, we aimed to assess the serological response and safety of the fourth booster ...
Camilla Di Nunzio, Luigi Cavanna, Chiara Citterio, Giuliana Lo Cascio, Claudia Biasini   +4 more
core   +1 more source

Rewriting Tumor Immunity With Bacterial Membrane Vesicles: A Versatile and Potent Therapeutic Strategy

Advanced NanoBiomed Research, EarlyView.
Bacterial membrane vesicles (BMVs) emerge as promising platforms for cancer immunotherapy owing to their intrinsic adjuvant properties and tunable cargo delivery capabilities. Their ability to modulate the tumor microenvironment, enhance antitumor immune responses, and support personalized therapeutic strategies highlights their growing potential as ...
Md Sifat Rahi, Md Mijanur Rahman, Asma Talukder, Urooj Yousaf Virk, Jennifer C. Wilson, Nigel McMillan, Ming Q. Wei   +6 more
wiley   +1 more source

Editorial: Pandemic preparedness in vaccine safety and regulation. [PDF]

Front Drug Saf Regul
Younus MM, van Hunsel F.
europepmc   +1 more source

Safety and Feasibility of Magnetic Separation‐Based Blood Purification

Advanced NanoBiomed Research, EarlyView.
We present the preclinical biological safety and translational feasibility of a magnetic nanoparticle‐based extracorporeal blood purification platform for removal of disease‐causing blood factors. ISO 10993‐compliant studies and exaggerated worst‐case exposure models demonstrate efficient nanoparticle extraction (≥99.9%), favorable biocompatibility ...
Carlos A. Mora, Laurine Rijsbergen, Jan Waskowski, Gaelle Clermont, Florian Dingreville, Chandrashekara Vishwanath, Rajesh Karunanithi, Alexander Gogos, Jean‐Claude Metzger, Manuel Baumgartner, Joerg C. Schefold, Inge K. Herrmann   +11 more
wiley   +1 more source

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance. [PDF]

Stat Med
Silva IR, Wang L, Maro JC.
europepmc   +1 more source